Hormones & Endocrinology
Explainer
The Biological Differences Between Conventional HRT and Compounded Bioidentical Hormones
11 sources · 5d ago
Diabetes Care
FDA Approves First Once-Weekly Basal Insulin, Ending Daily Injections for Millions of Diabetes Patients
5 sources · 10d ago
Menopause Care
FDA Removes Black Box Warnings on Menopausal Hormone Therapy, Reversing Two Decades of Policy
6 sources · 16d ago
More in Hormones & Endocrinology
Diabetes CareExplainer
FDA Approves First Once-Weekly Basal Insulin for Type 2 Diabetes
Clinical Endocrinologists 40%Type 1 Diabetes Advocates 30%Primary Care Providers 30%
7 sources · 22d ago
Menopause CarePolicy Reversal
FDA Removes Black Box Warning on Menopausal Hormone Therapy, Reversing Two Decades of Caution
Regulatory & Medical Consensus 45%Clinical Specialists 40%Patient Safety Advocates 15%
8 sources · 33d ago
Menopause CareMedical Breakthrough
New Non-Hormonal Drug Class Matches HRT Effectiveness for Menopause Hot Flashes
Medical Consensus 50%Breast Cancer Advocacy 30%HRT Proponents 20%
6 sources · 36d ago
Menopause CarePolicy Reversal
FDA Removes Boxed Warnings for Breast Cancer and Dementia from Menopausal Hormone Therapy
Women's Health Advocates 45%Regulatory Leadership 35%Breast Cancer Organizations 20%
7 sources · 44d ago
Thyroid Eye DiseaseDrug Approval
Landmark Approval: First-in-Class Drug Lumvoa Cleared for Thyroid Eye Disease, Treating Both Active and Chronic Stages
Clinical Ophthalmologists 40%Patients & Advocates 35%Industry & Market Analysts 25%
7 sources · 48d ago
Bone HealthClinical Evidence
Real-World Data Shows Semaglutide Lowers Fracture Risk by 15% in Diabetics, Defying Weight Loss Expectations
Clinical Endocrinologists 40%Bone Health Researchers 35%Real-World Data Analysts 25%
2 sources · 55d ago
Menopause CarePolicy Reversal
FDA Removes Decades-Old Black Box Warning from Menopausal Hormone Therapy
Women's Health Specialists 45%Oncology & Risk Experts 30%Federal Regulators 25%
4 sources · 55d ago
Obesity MedicineTrial Results
Eli Lilly's Triple-Hormone Agonist Retatrutide Achieves 28% Weight Loss in Phase 3 Trial
Clinical Researchers 41%Industry Analysts 35%Patient Advocates 24%
3 sources · 58d ago
Menopause CareExplainer
Landmark 20-Year WHI Follow-up Reverses Hormone Therapy Fears for Younger Menopausal Women
Medical Consensus 50%Patient Advocates 30%Cautious Oncologists 20%
4 sources · 56d ago
ExplainerBioprinted Organs
Bioprinted Adrenal Tissue Restores Circadian Cortisol in Animal Models, Offering Functional Cure for Addison's Disease
Regenerative Medicine Researchers 45%Patient Advocacy Groups 35%Endocrinologists 20%
3 sources · 68d ago
Metabolic HealthExplainer
Global Consensus Redefines PCOS as 'Polyendocrine Metabolic Ovarian Syndrome' (PMOS) to Reflect Systemic Nature
Patient Advocacy Groups 40%Clinical Endocrinologists 35%Public Health Authorities 25%
5 sources · 68d ago
AcromegalyExplainer
FDA Approves Paltusotine as the First Once-Daily Oral Treatment for Acromegaly
Patients & Advocacy Groups 40%Endocrinologists & Clinicians 35%Pharmaceutical Developers 25%
6 sources · 71d ago
ExplainerEndocrinology
The Science of Cortisol: How the Body Processes Stress and the Evidence Behind 'Cortisol Balancing'
Clinical Endocrinologists 40%Psychoneuroendocrinology Researchers 35%Evidence-Based Wellness Advocates 25%
4 sources · 75d ago
ExplainerExercise Science
The 'Exercise Hormone' Irisin Directly Protects the Brain, Halting Neurodegeneration in New Study
Neurobiology Researchers 45%Clinical Neurologists 35%Exercise Physiologists 20%
3 sources · 75d ago
Metabolic ScienceExplainer
How Retatrutide Works: The Science Behind the 'Triple-G' Obesity Drug
Clinical Researchers 40%Metabolic Disease Patients 30%Drug Safety Regulators 30%
5 sources · 75d ago
ExplainerGLP-1 Science
The GLP-1 Revolution: How the 'Satiety Hormone' is Rewiring Heart and Brain Health
Metabolic Researchers 40%Neurology Investigators 35%Public Health Advocates 25%
5 sources · 92d ago